Molecular Allergen Component Resolved Diagnosis to Decide Immunotherapy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Molecular Allergen Component Resolved Diagnosis to Decide Immunotherapy — Stella

Recruiting

Back to Asthma trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Portugal

Faculty of Medicine Porto University/Centro Hospitalar de São João, Porto

Key details

Sponsor

Universidade do Porto

Collaborators

Sociedade Portuguesa de Alergologia e Imunologia Clinica

Enrollment target

~210 participants

Started

July 2022

Primary completion

April 2026

Age range

5 Years and older

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov